DICE Therapeutics, Inc (NASDAQ:DICE) Given Average Recommendation of Hold by Brokerages kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Stifel Nicolaus downgraded shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a hold rating in a research report report published on Tuesday morning, The Fly reports. DICE has been the subject of several other research reports. Cowen assumed coverage on shares of DICE Therapeutics in a research report on Wednesday, […]
DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price objective among analysts […]
DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 8,010,000 shares, a decrease of 9.0% from the April 30th total of 8,800,000 shares. Currently, 20.8% of the company’s shares are sold short. Based on an average […]
Shares of DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) have been assigned a consensus rating of “Buy” from the eleven analysts that are presently covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have issued ratings on the stock in […]